![]() |
|
| Lamivudine(150 mg)+Zidovudine(300 mg)+Nevirapine(200 mg) | |||||||||||||||
|
Lami-Zido-Nevi DescriptionZidovudine and Lamivudine act by terminating the growth of the DNA chain and inhibiting the reverse transcriptase of HIV, where as Nevirapine is a non-nucleoside reverse transcriptase inhibtor. |
How to Use Lami-Zido-NeviEach film coated tablet contains :Lamivudine 150mg Zidovudine 300mg Nevirapine 200mg This medicine is not intended for use in paediatric patients. This combination is indicated for treatment of HIV infection,once patients have been stabilised on the maintainence regimen of NEVIRAPINE 200mg bd, and have demonstrated adequate tolerability to the same. 1 tablet twice daily is the usual dosage for this combination, contact your health care professional for more information. This medication should not be adminstered to patients who have just initiated therapy with Nevirapine. An initial lead in dosing of 200mg of Nevirapine once daily for 2 weeks is recommended and also to observe if the patient is reporting any adverse reactions to the same such as rashes, liver abnormalities. As this is a fixed dose combination, this medication should not be taken by anyone requiring a dosage adjustment and it should be discontinued if the patient experiences severe rash during thier lead in dosing of Nevirapine until the rash has resolved, the patient should not use this combination for treatment if they do not demonstrate adequate tolerability to Nevirapine. |